1290 Essex Small Cap Growth R holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.
1290 Essex Small Cap Growth Fund Class R ESCKX
- NAV / 1-Day Return 18.27 / +0.10 %
- Total Assets 115.2M
-
Adj. Expense Ratio
1.380%
- Expense Ratio 1.380%
- Distribution Fee Level Average
- Share Class Type Retirement, Medium
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 55%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 3:34 AM GMT+0
Morningstar’s Analysis ESCKX
Will ESCKX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Kiniksa Pharmaceuticals International PLC Class A | 2.74 | 3M | Healthcare |
Adaptive Biotechnologies Corp | 2.45 | 3M | Healthcare |
JPMorgan Prime Money Market IM | 2.33 | 3M | Cash and Equivalents |
CECO Environmental Corp | 2.24 | 3M | Industrials |
Travere Therapeutics Inc Ordinary Shares | 1.97 | 2M | Healthcare |
Leonardo DRS Inc | 1.96 | 2M | Industrials |
Oceaneering International Inc | 1.72 | 2M | Energy |
BrainsWay Ltd ADR | 1.72 | 2M | Healthcare |
Tower Semiconductor Ltd | 1.57 | 2M | Technology |
Lincoln Educational Services Corp | 1.52 | 2M | Consumer Defensive |